The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac disease

Stem Cells and Development

Volumn 22, Issue 2, 2013, Pages 216-223

  Mozid, Abdul M ^a   Jones, Dan ^a   Arnous, Samer ^a   Saunders, Natalie ^b   Wragg, Andrew ^a   Martin, John ^c   Agrawal, Samir ^b   Mathur, Anthony ^a  

^a LONDON CHEST HOSPITAL   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE HEART INFARCTION; ADULT; AGED; AGING; ARTICLE; CD34 SELECTION; CELL COUNT; CELL FUNCTION; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL PROGENITOR CELL; FEMALE; HEART DISEASE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INTRACORONARY INFUSION; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEM CELL MOBILIZATION;

ADULT; AGE FACTORS; AGED; ANTIGENS, CD34; BONE MARROW; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CELL COUNT; CELL MOVEMENT; COLONY-FORMING UNITS ASSAY; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART FAILURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECOMBINANT PROTEINS; STEM CELLS; TIME FACTORS;

EID: 84872444667     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0139     Document Type: Article

References (33)

1. Orlic D, J Kajstura, S Chimenti, I Jakoniuk, SM Anderson, B Li, J Pickel, R McKay, B Nadal-Ginard, et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705. (Pubitemid 32290358)
2. Schachinger V, S Erbs, A Elsasser, W Haberbosch, R Hambrecht, H Holschermann, J Yu, R Corti, DG Mathey, et al. (2006). Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27:2775-2783. (Pubitemid 44871463)
3. Strauer BE, M Yousef and CM Schannwell. (2010). The acute and long-term effects of intracoronary stem cell transplantation in 191 patients with chronic heARt failure: the STARheart study. Eur J Heart Fail 12:721-729.
4. Fischer-Rasokat U, B Assmus, FH Seeger, J Honold, D Leistner, S Fichtlscherer, V Schachinger, T Tonn, H Martin, S Dimmeler and AM Zeiher. (2009). A pilot trial to assess potential effects of selective intracoronary bone marrowderived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ Heart Fail 2:417-423.
5. Orlic D, J Kajstura, S Chimenti, F Limana, I Jakoniuk, F Quaini, B Nadal-Ginard, DM Bodine, A Leri and P Anversa. (2001). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98:10344-10349. (Pubitemid 32803022)
6. Leone AM, MB Giannico, I Bruno, A Giordano, V Zaccone,M Perfetti, G Niccoli, I Porto, F Burzotta, et al. (2011). Safety and efficacy of G-CSF in patients with ischemic heart failure: the CORNER (Cell Option For Recovery in the Non-Eligible Patients for Revascularization) study. Int J Cardiol 150:75-78.
7. Peichev M, AJ Naiyer, D Pereira, Z Zhu, WJ Lane, M Williams, MC Oz, DJ Hicklin, L Witte, MA Moore and S Rafii. (2000) Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors. Blood 95:952-958. (Pubitemid 30062717)
8. Mathur A and JF Martin. (2004). Stem cells and repair of the heart. Lancet 364:183-192. (Pubitemid 38898735)
9. Murry CE, MH Soonpaa, H Reinecke, H Nakajima, HO Nakajima, M Rubart, KB Pasumarthi, JI Virag, SH Bartelmez, et al. (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668. (Pubitemid 38524810)
10. Hirsch A, R Nijveldt, PA van der Vleuten, JG Tijssen, WJ van der Giessen, RA Tio, J Waltenberger, JM Ten Berg, PA Doevendans, et al. (2011). Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J 32:1736-1747.
11. Diederichsen AC, JE Moller, P Thayssen, AB Junker, L Videbaek, SG Saekmose, T Barington, M Kristiansen and M Kassem. (2008). Effect of repeated intracoronary injection of bone marrow cells in patients with ischaemic heart failure the Danish stem cell study-congestive heart failure trial (DanCell-CHF). Eur J Heart Fail 10:661-667.
12. DuckersHJ, JHoutgraaf,C Hehrlein, J Schofer, JWaltenberger, A Gershlick, J Bartunek, C Nienaber, C Macaya, et al. (2011). Final results of a phase IIa, randomized, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. EuroIntervention 6:805-812.
13. Heeschen C, R Lehmann, J Honold, B Assmus, A Aicher, DH Walter, H Martin, AM Zeiher and S Dimmeler. (2004). Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109:1615-1622. (Pubitemid 38451717)
14. Dimmeler S and A Leri. (2008). Aging and disease as modifiers of efficacy of cell therapy. Circ Res 102:1319-1330.
15. Moskowitz CH, JR Glassman, D Wuest, P Maslak, L Reich, A Gucciardo,NCoady-Lyons,ADZelenetz and SD Nimer. (1998). Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma. Clin Cancer Res 4:311-316. (Pubitemid 28122743)
16. Yeo C and A Mathur. (2009). Autologous bone marrowderived stem cells for ischemic heart failure: REGENERATEIHD trial. Regen Med 4:119-127.
17. Arnous S, A Mozid and A Mathur. (2011). The bone marrow derived adult stem cells for dilated cardiomyopathy (REGENERATE-DCM) trial: study design. Regen Med 6:525-533.
18. Fuchs S, R Kornowski, G Weisz, LF Satler, PC Smits, P Okubagzi, R Baffour, A Aggarwal, NJ Weissman, et al. (2006). Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. Am J Cardiol 97:823-829.
19. Perin EC, GV Silva, TD Henry, MG Cabreira-Hansen, WH Moore, SA Coulter, JP Herlihy, MR Fernandes, BY Cheong, et al. (2011). A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am Heart J 161:1078-1087.
20. Assmus B, Fischer-Rasokat U, J Honold, FH Seeger, S Fichtlscherer, T Tonn, E Seifried, V Schachinger, S Dimmeler and AM Zeiher. (2007). Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circ Res 100:1234-1241. (Pubitemid 46684137)
21. Werner N, S Kosiol, T Schiegl, P Ahlers, K Walenta, A Link, M Bohm and G Nickenig. (2005). Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999-1007. (Pubitemid 41262334)
22. Turan RG, M Brehm, M Koestering, Z Tobias, T Bartsch, S Steiner, F Picard, P Ebner, CM Schannwell and BE Strauer. (2007). Factors influencing spontaneous mobilization of CD34 + and CD133 + progenitor cells after myocardial infarction. Eur J Clin Invest 37:842-851. (Pubitemid 350029211)
23. Vasa M, S Fichtlscherer, A Aicher, K Adler, C Urbich, H Martin, AM Zeiher and S Dimmeler. (2001). Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:E1-E7.
24. Losordo DW, RA Schatz, CJ White, JE Udelson, V Veereshwarayya, M Durgin, KK Poh, RWeinstein,MKearney, et al. (2007). Intramyocardial transplantation of autologous CD34 + stem cells for intractable angina: a phase I/IIa doubleblind, randomized controlled trial. Circulation 115:3165-3172. (Pubitemid 47018140)
25. Kang S, Y Yang, CJ Li and R Gao. (2007). Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials. Clin Ther 29:2406-2418.
26. Wen Y, L Meng, Y Ding and J Ouyang. (2011). Autologous transplantation of blood-derived stem/progenitor cells for ischaemic heart disease. Int J Clin Pract 65:858-865.
27. Bensinger WI, R Clift, P Martin, FR Appelbaum, T Demirer, T Gooley, K Lilleby, S Rowley, J Sanders, R Storb and CD Buckner. (1996). Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 88:2794-2800. (Pubitemid 26327536)
28. Korbling M, D Przepiorka, YO Huh, H Engel, BK Van, S Giralt, B Andersson, Kleine HD, D Seong and AB Deisseroth. (1995). Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 85: 1659-1665.
29. Bodine DM, NE Seidel and D Orlic. (1996). Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 88:89-97. (Pubitemid 26230675)
30. de HG, B Dontje, C Engel, M Loeffler and W Nijhof. (1995). The kinetics of murine hematopoietic stem cells in vivo in response to prolonged increased mature blood cell production induced by granulocyte colony-stimulating factor. Blood 86:2986-2992.
31. Assmus B, V Schä chinger, C Teupe, M Britten, R Lehmann, N Dö bert, F Grü nwald, A Aicher, C Urbich, et al. (2002). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009-3017. (Pubitemid 35440281)
32. Assmus B, J Honold, V Schachinger, M Britten, U Fischer-Rasokat, R Lehmann, C Teupe, K Pistorius, H Martin and N Abolmaali. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355:1222-1232. (Pubitemid 44427446)
33. Valgimigli M, GM Rigolin, A Fucili, MD Porta, O Soukhomovskaia, P Malagutti, AM Bugli, LZ Bragotti, G Francolini, et al. (2004). CD34 + and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110:1209-1212. (Pubitemid 39202334)